CONMED Corporation to Announce First Quarter 2023 Financial Results on April 26, 2023
April 04 2023 - 4:05PM
Business Wire
CONMED Corporation (NYSE: CNMD) today announced that it
will report financial results for the first quarter 2023 after the
market close on Wednesday, April 26, 2023. The Company’s management
will host a conference call at 4:30 p.m. ET that same day to
discuss the results.
To participate in the conference call via telephone, please
click here to pre-register and obtain the dial-in number and
passcode.
This conference call will also be webcast and can be accessed
from the “Investors” section of CONMED's website at www.conmed.com.
The webcast replay of the call will be available at the same site
approximately one hour after the end of the call.
About CONMED Corporation
CONMED is a medical technology company that provides surgical
devices and equipment for minimally invasive procedures. The
Company’s products are used by surgeons and physicians in a variety
of specialties, including orthopedics, general surgery, gynecology,
thoracic surgery, and gastroenterology. For more information, visit
www.conmed.com.
Forward-Looking Statements
This press release and the associated conference call may
contain forward-looking statements based on certain assumptions and
contingencies that involve risks and uncertainties, which could
cause actual results, performance, or trends to differ materially
from those expressed in the forward-looking statements herein or in
previous disclosures. For example, in addition to general industry
and economic conditions, factors that could cause actual results to
differ materially from those in the forward-looking statements may
include, but are not limited to, the risks posed to the Company’s
business, financial condition, and results of operations by the
COVID-19 global pandemic and the various government responses to
the pandemic, including deferral of surgeries, reductions in
hospital and ambulatory surgery center operating volumes,
disruption to potential supply chain reliability; any assumptions
underlying any of the foregoing as well as the risk factors
discussed in the Company's Annual Report on Form 10-K for the full
year ended December 31, 2022, listed under the heading
Forward-Looking Statements in the Company’s most recently filed
Form 10-K and other risks and uncertainties which may be detailed
from time to time in reports filed by CONMED with the SEC. Any and
all forward-looking statements are made pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995
and relate to the Company’s performance on a going-forward basis.
The Company believes that all forward-looking statements made by it
have a reasonable basis, but there can be no assurance that
management’s expectations, beliefs or projections as expressed in
the forward-looking statements will actually occur or prove to be
correct.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230404006035/en/
CONMED Corporation Todd W. Garner Chief
Financial Officer 727-214-2975
ToddGarner@conmed.com
CONMED (NYSE:CNMD)
Historical Stock Chart
From May 2024 to Jun 2024
CONMED (NYSE:CNMD)
Historical Stock Chart
From Jun 2023 to Jun 2024